Well‐differentiated papillary mesothelial tumour: histologic, molecular and genetic features support a benign clonal neoplasm despite diffuse peritoneal involvement

Documenti analoghi

• Glutamine fructose 6‐phosphate transaminase‐2 as a marker of mesothelial proliferations
  di: Andrew Churg, et al.
  Pubblicazione: (2026)
• Analysis of benign neoplasms of the rete testis formerly termed “Sertoliform cystadenomas” demonstrates that they are not Sertoli cell tumours with intra‐rete growth
  di: Katrina Collins, et al.
  Pubblicazione: (2025)
• Genomic analysis of primary epithelial neoplasms of the seminal vesicle identifies a subset of mucinous cystic tumours driven by KRAS mutations
  di: Katrina Collins, et al.
  Pubblicazione: (2024)
• Diagnostic accuracy and clinical outcomes of patients diagnosed with clear cell papillary renal cell tumour at renal mass biopsy
  di: Alexander Oberc, et al.
  Pubblicazione: (2025)
• Response to: ‘Glutamine–fructose‐6‐phosphate transaminase 2 as a marker of mesothelial proliferation’
  di: Jia Wei, et al.
  Pubblicazione: (2026)